Clinical trial
A Randomized, Double-Blind, Study of the Analgesic Efficacy and Safety of Flexible Dose Q8003 Versus Low Dose Q8003 in Patients Who Have Undergone Primary Unilateral Total Knee Arthroplasty
NCT01055015 is registered in ClinicalTrials.gov with QRxPharma Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Study of the Analgesic Efficacy and Safety of Flexible Dose Q8003 Versus Low Dose Q8003 in Patients Who Have Undergone Primary Unilateral Total Knee Arthroplasty
- Lead sponsor
- QRxPharma Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- December 31, 2010
- Enrollment
- 141 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.